Total Payments
$526,036
2024 Payments
$36,496
Companies
40
Transactions
845
Medicare Patients
4,927
Medicare Billing
$879,284
Payment Breakdown by Category
Other$371,134 (70.6%)
Consulting$98,088 (18.6%)
Travel$36,449 (6.9%)
Food & Beverage$19,775 (3.8%)
Education$589.53 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $287,269 | 147 | 54.6% |
| Consulting Fee | $98,088 | 43 | 18.6% |
| Honoraria | $81,265 | 44 | 15.4% |
| Travel and Lodging | $36,449 | 149 | 6.9% |
| Food and Beverage | $19,775 | 445 | 3.8% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $2,600 | 1 | 0.5% |
| Education | $589.53 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Relypsa, Inc. | $86,583 | 114 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $64,458 | 82 | $0 (2023) |
| GlaxoSmithKline, LLC. | $55,971 | 52 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $41,634 | 87 | $0 (2023) |
| CALLIDITAS THERAPEUTICS US INC. | $39,643 | 44 | $0 (2024) |
| Vifor Pharma, Inc. | $36,999 | 36 | $0 (2023) |
| Horizon Therapeutics plc | $27,665 | 70 | $0 (2023) |
| Veloxis Pharmaceuticals, Inc. | $25,848 | 39 | $0 (2024) |
| Rockwell Medical, Inc. | $24,342 | 25 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $23,865 | 41 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $36,496 | 46 | CALLIDITAS THERAPEUTICS US INC. ($16,166) |
| 2023 | $95,503 | 125 | Calliditas Therapeutics US Inc. ($16,940) |
| 2022 | $96,113 | 195 | Vifor Pharma, Inc. ($27,030) |
| 2021 | $75,923 | 126 | Aurinia Pharma U.S., Inc. ($16,914) |
| 2020 | $60,931 | 94 | Rockwell Medical, Inc. ($14,393) |
| 2019 | $65,980 | 112 | Relypsa, Inc. ($31,895) |
| 2018 | $59,613 | 84 | Relypsa, Inc. ($28,272) |
| 2017 | $35,476 | 63 | Relypsa, Inc. ($20,547) |
All Payment Transactions
845 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | — | Consulting Fee | Cash or cash equivalent | $8,322.00 | General |
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $82.39 | General |
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $37.11 | General |
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| 12/04/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $960.00 | General |
| Category: Nephrology | ||||||
| 11/26/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $1,920.00 | General |
| Category: Nephrology | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $50.41 | General |
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | — | Food and Beverage | In-kind items and services | $47.02 | General |
| 11/12/2024 | Otsuka America Pharmaceutical, Inc. | — | Travel and Lodging | In-kind items and services | $800.31 | General |
| 08/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.31 | General |
| 08/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: Nephrology | ||||||
| 08/16/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $103.54 | General |
| Category: Nephrology | ||||||
| 06/06/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $1,920.00 | General |
| Category: Nephrology | ||||||
| 05/22/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $129.77 | General |
| Category: Nephrology | ||||||
| 05/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $162.31 | General |
| Category: Nephrology | ||||||
| 05/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $53.98 | General |
| Category: Nephrology | ||||||
| 04/24/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Honoraria | Cash or cash equivalent | $4,320.00 | General |
| Category: Nephrology | ||||||
| 04/18/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $417.36 | General |
| 04/18/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $53.98 | General |
| 04/05/2024 | Travere Therapeutics, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,750.00 | General |
| 03/23/2024 | Travere Therapeutics, Inc. | — | Travel and Lodging | Cash or cash equivalent | $245.81 | General |
| 03/23/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $145.00 | General |
| Category: Nephrology | ||||||
| 03/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 03/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 03/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $60.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 367 | 1,053 | $129,285 | $40,251 |
| 2022 | 26 | 1,553 | 31,606 | $963,388 | $274,398 |
| 2021 | 21 | 1,398 | 28,025 | $856,330 | $256,553 |
| 2020 | 21 | 1,609 | 48,023 | $1.1M | $308,082 |
Total Patients
4,927
Total Services
108,707
Medicare Billing
$879,284
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 326 | $94,309 | $29,446 | 31.2% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 18 | 540 | $13,662 | $3,412 | 25.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 36 | $6,929 | $2,575 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,177 | $1,891 | 30.6% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 36 | $1,980 | $1,356 | 68.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,450 | $1,093 | 31.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 33 | $2,219 | $347.70 | 15.7% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 33 | 56 | $560.00 | $129.92 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 357 | 609 | $176,178 | $57,841 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 317 | 818 | $167,706 | $47,007 | 28.0% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 30 | 135 | $94,920 | $32,127 | 33.8% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2022 | 50 | 3,940 | $99,682 | $25,363 | 25.4% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 28 | 77 | $67,209 | $21,306 | 31.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 154 | 160 | $60,120 | $17,157 | 28.5% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2022 | 39 | 23,970 | $100,939 | $14,918 | 14.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 45 | 53 | $31,636 | $12,261 | 38.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 74 | 147 | $30,231 | $8,630 | 28.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 62 | $18,196 | $5,147 | 28.3% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2022 | 22 | 811 | $22,140 | $5,143 | 23.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 38 | 38 | $16,766 | $4,677 | 27.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 44 | 62 | $13,898 | $3,458 | 24.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 51 | $9,816 | $3,102 | 31.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 14 | 18 | $9,127 | $3,017 | 33.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 12 | 54 | $3,672 | $2,380 | 64.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 59 | 195 | $13,097 | $2,254 | 17.2% |
About Dr. Michael Germain, MD
Dr. Michael Germain, MD is a Nephrology healthcare provider based in Springfield, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376533117.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Germain, MD has received a total of $526,036 in payments from pharmaceutical and medical device companies, with $36,496 received in 2024. These payments were reported across 845 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($287,269).
As a Medicare-enrolled provider, Germain has provided services to 4,927 Medicare beneficiaries, totaling 108,707 services with total Medicare billing of $879,284. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Springfield, MA
- Active Since 10/24/2005
- Last Updated 03/05/2014
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1376533117
Products in Payments
- Veltassa (Drug) $103,025
- TARPEYO (Drug) $39,643
- LOKELMA (Drug) $39,393
- BENLYSTA (Biological) $31,952
- KRYSTEXXA (Biological) $27,711
- TRIFERIC (Drug) $22,342
- Envarsus (Drug) $20,581
- JYNARQUE (Drug) $18,255
- LUPKYNIS (Drug) $16,914
- Rayaldee (Drug) $16,630
- SOLIRIS (Drug) $14,683
- JESDUVROQ (Drug) $14,269
- PURIFIED CORTROPHIN GEL (Drug) $9,714
- TAVNEOS (Drug) $8,050
- Parsabiv (Biological) $7,708
- Nephrocheck (Device) $7,339
- ULTOMIRIS (Biological) $6,941
- Ultomiris (Drug) $5,613
- ENVARSUS (Drug) $5,145
- Tavneos (Drug) $2,510
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Springfield
Merry Downer, M.d, M.D
Nephrology — Payments: $121,311
Nephrology $121,311
Dr. Jonathan Slater, M.d, M.D
Nephrology — Payments: $87,645
Nephrology $87,645
Sanju Varghese, Md, MD
Nephrology — Payments: $54,504
Nephrology $54,504
Mr. Ramesh Marahatta, Md, MD
Nephrology — Payments: $13,383
Nephrology $13,383
Thomas Ebert, M.d, M.D
Nephrology — Payments: $9,270
Nephrology $9,270
Dr. Barbara Greco, Md, MD
Nephrology — Payments: $7,756
Nephrology $7,756